Onconova Therapeutics Inc

Company Snapshot
12 Penns Trail
Newtown, PA 18940
United States
Sector: Healthcare
Industry: Biotechnology
Full Time Employees: 17
https://www.onconova.com
Please select from the dropdown
Company Financials

2020
2021
2022
Gross Profit
Operating Income
($24,993,000)
($16,496,000)
($19,627,000)
Net Income
($25,157,000)
($16,163,000)
($18,964,000)
2020
Gross Profit
Operating Income
($24,993,000)
Net Income
($25,157,000)
2021
Gross Profit
Operating Income
($16,496,000)
Net Income
($16,163,000)
2022
Gross Profit
Operating Income
($19,627,000)
Net Income
($18,964,000)
The above data on Onconova Therapeutics Inc came from annual proxy statements to the SEC. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov
Top Executives
Total Cash info
Equity info
Other info
Total Compensation
Top Executives
Total Compensation
Steven Fruchtman
Director, President and Chief Executive Officer
$881,769
$418,923
$26,090
$1,326,782
Steven Fruchtman
$1,326,782
Director, President and Chief Executive Officer
Mark Guerin
Chief Operating Officer, Chief Financial Officer and Principal Accounting Officer
$596,383
$215,432
$32,884
$844,699
Mark Guerin
$844,699
Chief Operating Officer, Chief Financial Officer and Principal Accounting Officer
James Marino
Chairman of the Board
$82,500
$72,009
$0
$154,509
James Marino
$154,509
Chairman of the Board
Jack Stover
Independent Director
$67,500
$72,009
$0
$139,509
Jack Stover
$139,509
Independent Director
Viren Mehta
Independent Director
$59,167
$72,009
$0
$131,176
Viren Mehta
$131,176
Independent Director
Onconova Therapeutics Inc listed the above executives on its annual proxy statement to the SEC for the fiscal year of 2022. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov

The sum of all cash payments made to an individual for services during a given year. It is comprised of yearly Base Pay and Bonuses

To view more detailed proxy data including previous years contact our sales team.

Contact Us

The value of stock and option awards plus long term incentives granted.

To view more detailed proxy data including previous years contact our sales team.

Contact Us

This covers all compensation that don't fit in any of these other standard categories

To view more detailed proxy data including previous years contact our sales team.

Contact Us